Mesothelioma is an aggressive cancer that severely impacts the quality of life of patients and their families. This medical condition often poses a tough challenge as it often leaves those ...

A disease as aggressive as mesothelioma demands a system that can keep pace. Instead, our fragmented approach leaves too many veterans behind.

Mesothelioma is a rare but almost always fatal form of cancer linked to asbestos exposure. It is predominantly detected among ...

Mesothelioma is a rare malignancy affecting people exposed to asbestos. Each year, across all cancer diagnoses, mesothelioma accounts for fewer than 3,000 cases. As a result, research interest in this ...

Peritoneal mesothelioma develops in the lining around the abdominal organs. Learn what causes it, how doctors treat it, and the outlook after treatment.

Approximately 3,000 new cases of mesothelioma are diagnosed each year in the U.S., and there are approximately 2,500 mesothelioma-related deaths each year in the U.S.

Mesothelioma is a rare cancer that affects the lining surrounding organs, usually in the chest and abdomen. Treating this disease has been challenging because in most cases it is not possible to ...

As mesothelioma is an orphan disease, advances in treatment are very rare. The US Food and Drug Administration (FDA) approved the first chemotherapy approach in 2004. This treatment consisted of a ...

Mesothelioma Market Outlook 2025-2035: The mesothelioma market reached a value of USD 464.2 Million in 2024. Looking forward, IMARC Group expects the 7MM to reach USD 972.0 Million by 2035, exhibiting ...

Dr. Hedy Kindler joins us on the podcast to discuss the latest update to the treatment of pleural mesothelioma guideline. She discusses the latest changes to the updated recommendations across topics ...

Merck & Co. Inc. said Wednesday the U.S. Food and Drug Administration has approved its blockbuster cancer drug Keytruda as a treatment for malignant plural mesothelioma, a rare cancer associated ...